Kaiser Permanente-Cadillac — Los Angeles, California

Kaiser Permanente-Cadillac is a clinical research site located in Los Angeles, California, United States 90034.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Kaiser Permanente-Cadillac has participated in 37 clinical trials with 9 currently active.

Therapeutic areas: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente-Cadillac?

Kaiser Permanente-Cadillac has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente-Cadillac conducted?

Kaiser Permanente-Cadillac has 37 clinical trials on record, with 9 currently active. Their work covers Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Is Kaiser Permanente-Cadillac accredited by Crixeo Health?

Yes — Kaiser Permanente-Cadillac holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Kaiser Permanente-Cadillac?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.